109 related articles for article (PubMed ID: 8274197)
1. Structural compartmentalization of MHC class II signaling function.
Wade WF; Davoust J; Salamero J; André P; Watts TH; Cambier JC
Immunol Today; 1993 Nov; 14(11):539-46. PubMed ID: 8274197
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
3. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
Lee JM; McKean DJ; Watts TH
J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of class II MHC allelic control of T cell responses.
Racioppi L; Ronchese F; Schwartz RH; Germain RN
J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150
[TBL] [Abstract][Full Text] [Related]
5. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
Harton JA; Bishop GA
J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
[TBL] [Abstract][Full Text] [Related]
6. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
[TBL] [Abstract][Full Text] [Related]
8. T cell recognition of self and altered self antigens.
Nicholson LB; Kuchroo VK
Crit Rev Immunol; 1997; 17(5-6):449-62. PubMed ID: 9419432
[TBL] [Abstract][Full Text] [Related]
9. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.
Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J
Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029
[TBL] [Abstract][Full Text] [Related]
10. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
11. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
Holling TM; Schooten E; van Den Elsen PJ
Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB.
Kaas Q; Lefranc MP
In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793
[TBL] [Abstract][Full Text] [Related]
13. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
14. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
15. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.
Braunstein NS; Germain RN; Loney K; Berkowitz N
J Immunol; 1990 Sep; 145(6):1635-45. PubMed ID: 1697304
[TBL] [Abstract][Full Text] [Related]
16. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
Watts C
Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of H-2 T (Tla) region class I MHC molecules.
Teitell M; Cheroutre H; Panwala C; Holcombe H; Eghtesady P; Kronenberg M
Crit Rev Immunol; 1994; 14(1):1-27. PubMed ID: 7741975
[TBL] [Abstract][Full Text] [Related]
18. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B
J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609
[TBL] [Abstract][Full Text] [Related]
19. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
20. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
